Zacks Investment ResearchFri, 03 Apr 2026 14:40:49 GMTExelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?EXEL+1.56%
Zacks Investment ResearchWed, 01 Apr 2026 14:46:07 GMTHere's Why Exelixis (EXEL) is a Strong Growth StockEXEL+1.56%
The Motley FoolTue, 31 Mar 2026 23:00:00 GMTExelixis: A Strong Contender in the Cancer Drug MarketEXEL+1.56%
Zacks Investment ResearchWed, 18 Mar 2026 14:41:08 GMTHere's Why Exelixis (EXEL) is a Strong Value StockEXEL+1.56%
The Motley FoolWed, 18 Mar 2026 12:30:00 GMTThe Best Healthcare Stocks to Buy With $50 Right NowEXEL+1.56%
Zacks Investment ResearchThu, 12 Mar 2026 14:45:20 GMTHere's Why Exelixis (EXEL) is a Strong Growth StockEXEL+1.56%
Seeking AlphaWed, 11 Mar 2026 18:12:23 GMTExelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptEXEL+1.56%
Seeking AlphaWed, 11 Mar 2026 15:52:21 GMTExelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 TranscriptEXEL+1.56%
Seeking AlphaTue, 10 Mar 2026 16:40:14 GMTExelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 TranscriptEXEL+1.56%
Seeking AlphaWed, 04 Mar 2026 06:52:14 GMTExelixis, Inc. (EXEL) Presents at TD Cowen 46th Annual Health Care Conference TranscriptEXEL+1.56%
Zacks Investment ResearchMon, 02 Mar 2026 15:41:43 GMTWhy Exelixis (EXEL) is a Top Value Stock for the Long-TermEXEL+1.56%
The Motley FoolSat, 28 Feb 2026 09:37:00 GMT3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next DecadeEXEL+1.56%
Zacks Investment ResearchTue, 24 Feb 2026 15:50:37 GMTHere's Why Exelixis (EXEL) is a Strong Momentum StockEXEL+1.56%
The Motley FoolFri, 20 Feb 2026 20:45:00 GMTExelixis: The Cash‑Generating Biotech That I Think Deserves a Closer Look in 2026EXEL+1.56%
Zacks Investment ResearchFri, 20 Feb 2026 15:46:09 GMTWhy Exelixis (EXEL) is a Top Growth Stock for the Long-TermEXEL+1.56%
Zacks Investment ResearchMon, 16 Feb 2026 15:16:18 GMTA Dive into Exelixis (EXEL) International Revenue Trends and ForecastsEXEL+1.56%
Zacks Investment ResearchFri, 13 Feb 2026 15:41:03 GMTHere's Why Exelixis (EXEL) is a Strong Value StockEXEL+1.56%
Zacks Investment ResearchThu, 12 Feb 2026 17:41:08 GMTEXEL or LQDA: Which Is the Better Value Stock Right Now?EXEL+1.56%
MarketBeatThu, 12 Feb 2026 17:40:23 GMTExelixis Reports Solid Earnings—Are New Highs Back on the Table?EXEL+1.56%
Zacks Investment ResearchWed, 11 Feb 2026 16:02:23 GMTEXEL Q4 Earnings and Revenues Beat, Colorectal Cancer Drug in FocusEXEL+1.56%
